Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 7/2008

01.07.2008 | Article

Antimicrobial resistance of Staphylococcus from otorrhea in chronic suppurative otitis media and comparison with results of all isolated Staphylococci

verfasst von: D. C. Park, S. K. Lee, C. I. Cha, S.-O. Lee, M. S. Lee, S. G. Yeo

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 7/2008

Einloggen, um Zugang zu erhalten

Abstract

Staphylococcus is one of the most important pathogenic bacteria in chronic suppurative otitis media (CSOM). The prevalence of pathogenic bacteria in patients with CSOM has not been compared with the prevalence rates in patients from other fields of medicine. We investigated the pathogenic bacteria in CSOM throughout Korea and annual isolation rates of methicillin-resistant Staphylococcus aureus (MRSA) over 6 years. Routine culture results and susceptibility data of CSOM isolated from 2000 to 2005 were collected from six general hospitals in Korea, along with the results of all clinically isolated Staphylococci from one tertiary care teaching hospital. Of the 1,162 bacteria identified in 1,360 CSOM patients, 628 (54.0%) were Staphylococci in CSOM. Of the latter, 288 (45.9%) were MRSA, which accounted for 24.8% of identified bacteria. Of the 5,988 clinically isolated Staphylococci from one tertiary care hospital, 3,712 (61.9%) were MRSA. All MRSA isolated from CSOM patients were sensitive to vancomycin and teicoplanin, and 88.2% were sensitive to sulfamethoxazole/trimethoprim. In contrast, these strains showed little or no sensitivity to oxacillin, clindamycin, penicillin, and erythromycin. Annual MRSA isolation rates showed no tendencies to increase or decrease. MRSA was the most frequently identified Staphylococcus in patients with otorrhea. The isolation rate of MRSA has not changed over 6 years. Continuous and periodic surveillance of MRSA is necessary to reduce the spread of antibiotic-resistant pathogens and to guide appropriate antibacterial therapy.
Literatur
1.
Zurück zum Zitat Jevons MP (1961) Celbenin-resistant Staphylococci (letter). BMJ 1:124CrossRef Jevons MP (1961) Celbenin-resistant Staphylococci (letter). BMJ 1:124CrossRef
2.
Zurück zum Zitat da Costa SS, Paparella MM, Schachern PA, Yoon TH, Kimberley BP (1992) Temporal bone histopathology in chronically infected ears with intact and perforated tympanic membranes. Laryngoscope 102:1229–1236PubMedCrossRef da Costa SS, Paparella MM, Schachern PA, Yoon TH, Kimberley BP (1992) Temporal bone histopathology in chronically infected ears with intact and perforated tympanic membranes. Laryngoscope 102:1229–1236PubMedCrossRef
4.
Zurück zum Zitat Koh EK (1996) The bacteriology of cholesteatoma. In: Korean Otologic Study Group (ed) Cholesteatoma. Chung-Ang Publishing, Seoul, pp 49–63 Koh EK (1996) The bacteriology of cholesteatoma. In: Korean Otologic Study Group (ed) Cholesteatoma. Chung-Ang Publishing, Seoul, pp 49–63
5.
Zurück zum Zitat Lee KS, Suh SB, Hing SJ, Shin JE (1998) A study of ofloxacin ear drops versus amoxicillin/clavulanic acid in treatment of chronic suppurative otitis media. Korean J Audiol 2:181–189 Lee KS, Suh SB, Hing SJ, Shin JE (1998) A study of ofloxacin ear drops versus amoxicillin/clavulanic acid in treatment of chronic suppurative otitis media. Korean J Audiol 2:181–189
6.
Zurück zum Zitat Campos A, Arias A, Betancor L, Rodriguez C, Hernandez AM, Sierra A (1998) Studies of common aerobic flora of human cerumen. J Laryngol Otol 112:613–616PubMed Campos A, Arias A, Betancor L, Rodriguez C, Hernandez AM, Sierra A (1998) Studies of common aerobic flora of human cerumen. J Laryngol Otol 112:613–616PubMed
7.
Zurück zum Zitat David W, Peter S, Joseph D, Wayne B (2001) Microbiology of normal external auditory canal. Laryngoscope 111:2054–2059CrossRef David W, Peter S, Joseph D, Wayne B (2001) Microbiology of normal external auditory canal. Laryngoscope 111:2054–2059CrossRef
8.
Zurück zum Zitat Crum NF, Lee RU, Thornton SA, Stine OC, Wallace MR, Barrozo C, Keefer-Norris A, Judd S, Russell KL (2006) Fifteen-year study of the changing epidemiology of methicillin-resistant Staphylococcus aureus. Am J Med 119:943–951PubMedCrossRef Crum NF, Lee RU, Thornton SA, Stine OC, Wallace MR, Barrozo C, Keefer-Norris A, Judd S, Russell KL (2006) Fifteen-year study of the changing epidemiology of methicillin-resistant Staphylococcus aureus. Am J Med 119:943–951PubMedCrossRef
9.
Zurück zum Zitat Boserbaum B, Jacobs MR, Cechner RL (1998) Prevalence and significance of methicillin-resistant Staphylococcus aureus in patients with cystic fibrosis. Pediatr Pulmonol 4:159–163CrossRef Boserbaum B, Jacobs MR, Cechner RL (1998) Prevalence and significance of methicillin-resistant Staphylococcus aureus in patients with cystic fibrosis. Pediatr Pulmonol 4:159–163CrossRef
10.
Zurück zum Zitat Damman TA, Wiens RM, Taylor GD (1998) Methicillin-resistant Staphylococcus aureus: identification of a community outbreak by monitoring of hospital isolates. Can J Public Health 79:312–314 Damman TA, Wiens RM, Taylor GD (1998) Methicillin-resistant Staphylococcus aureus: identification of a community outbreak by monitoring of hospital isolates. Can J Public Health 79:312–314
11.
Zurück zum Zitat Saravolatz LD, Pohlod DJ, Arking LM (1982) Community-acquired methicillin-resistant Staphylococcus aureus infections: a new source for nosocomial outbreak. Ann Intern Med 97:325–329PubMed Saravolatz LD, Pohlod DJ, Arking LM (1982) Community-acquired methicillin-resistant Staphylococcus aureus infections: a new source for nosocomial outbreak. Ann Intern Med 97:325–329PubMed
12.
Zurück zum Zitat Herold BC, Immergluck LC, Maranan MC, Lauderdale DS, Gaskin RE, Boyle-Vavra S, Leitch CD, Daum RS (1998) Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 279:593–598PubMedCrossRef Herold BC, Immergluck LC, Maranan MC, Lauderdale DS, Gaskin RE, Boyle-Vavra S, Leitch CD, Daum RS (1998) Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 279:593–598PubMedCrossRef
13.
Zurück zum Zitat Gottlieb RD, Shah MK, Perlman DC, Kimmelman CP (1992) Community-acquired methicillin-resistant Staphylococcus aureus infections in otolaryngology. Otolaryngol Head Neck Surg 107:434–437PubMed Gottlieb RD, Shah MK, Perlman DC, Kimmelman CP (1992) Community-acquired methicillin-resistant Staphylococcus aureus infections in otolaryngology. Otolaryngol Head Neck Surg 107:434–437PubMed
14.
Zurück zum Zitat Frank AL, Marcinak JF, Mangat PD, Tjhio JT, Kelkar S, Schreckenberger PC, Quinn JP (2002) Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children. Pediatr Infect Dis J 21:530–534PubMedCrossRef Frank AL, Marcinak JF, Mangat PD, Tjhio JT, Kelkar S, Schreckenberger PC, Quinn JP (2002) Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children. Pediatr Infect Dis J 21:530–534PubMedCrossRef
15.
Zurück zum Zitat Sattler CA, Mason EO Jr, Kaplan SL (2002) Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus in children. Pediatr Infect Dis J 21:910–916PubMedCrossRef Sattler CA, Mason EO Jr, Kaplan SL (2002) Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus in children. Pediatr Infect Dis J 21:910–916PubMedCrossRef
16.
Zurück zum Zitat Changers HF (2001) The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis 7:178–182CrossRef Changers HF (2001) The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis 7:178–182CrossRef
17.
Zurück zum Zitat Daum RS, Ito T, Hiramatsu K, Hussain F, Mongkolrattanothai K, Jamklang M, Boyle-Vavra S (2002) A novel methicillin-resistance cassette in community-acquired methicillin-resistant Staphylococcus aureus isolates of diverse genetic backgrounds. J Infect Dis 186:1344–1347PubMedCrossRef Daum RS, Ito T, Hiramatsu K, Hussain F, Mongkolrattanothai K, Jamklang M, Boyle-Vavra S (2002) A novel methicillin-resistance cassette in community-acquired methicillin-resistant Staphylococcus aureus isolates of diverse genetic backgrounds. J Infect Dis 186:1344–1347PubMedCrossRef
18.
Zurück zum Zitat Diep BA, Sensabaugh GF, Somboona NS, Carleton HA, Perdreau-Remington F (2004) Widespread skin and soft-tissue infections due to two methicillin-resistant Staphylococcus aureus strains harboring the genes for Panton-Valentine leucocidin. J Clin Microbiol 42:2080–2084PubMedCrossRef Diep BA, Sensabaugh GF, Somboona NS, Carleton HA, Perdreau-Remington F (2004) Widespread skin and soft-tissue infections due to two methicillin-resistant Staphylococcus aureus strains harboring the genes for Panton-Valentine leucocidin. J Clin Microbiol 42:2080–2084PubMedCrossRef
19.
Zurück zum Zitat Almer LS, Shortridge VD, Nilius AM, Beyer JM, Soni NB, Bui MH, Stone GG, Flamm RK (2002) Antimicrobial susceptibility and molecular characterization of community-acquired methicillin-resistant Staphylococcus aureus. Diagn Microbiol Infect Dis 43:225–232PubMedCrossRef Almer LS, Shortridge VD, Nilius AM, Beyer JM, Soni NB, Bui MH, Stone GG, Flamm RK (2002) Antimicrobial susceptibility and molecular characterization of community-acquired methicillin-resistant Staphylococcus aureus. Diagn Microbiol Infect Dis 43:225–232PubMedCrossRef
20.
Zurück zum Zitat Hiu R, Coyne M (2004) Methicillin resistant Staphylococcus aureus (MRSA). SCIEH Wkly Rep 38:59–60 Hiu R, Coyne M (2004) Methicillin resistant Staphylococcus aureus (MRSA). SCIEH Wkly Rep 38:59–60
21.
Zurück zum Zitat Department of Health. The third year of regional and national analyses of the Department of Health’s mandatory MRSA surveillance scheme in England: April 2001-March 2004. CDR Wkly Rep 14:1–6 Department of Health. The third year of regional and national analyses of the Department of Health’s mandatory MRSA surveillance scheme in England: April 2001-March 2004. CDR Wkly Rep 14:1–6
22.
Zurück zum Zitat Gould IM (2005) The clinical significance of methicillin-resistant Staphylococcus aureus. J Hosp Infect 61:277–282PubMedCrossRef Gould IM (2005) The clinical significance of methicillin-resistant Staphylococcus aureus. J Hosp Infect 61:277–282PubMedCrossRef
23.
Zurück zum Zitat Santos F, Mankarious LA, Eavey RD (2000) Methicillin-resistant Staphylococcus aureus: pediatric otitis. Arch Otolaryngol Head Neck Surg 126:1383–1385PubMed Santos F, Mankarious LA, Eavey RD (2000) Methicillin-resistant Staphylococcus aureus: pediatric otitis. Arch Otolaryngol Head Neck Surg 126:1383–1385PubMed
Metadaten
Titel
Antimicrobial resistance of Staphylococcus from otorrhea in chronic suppurative otitis media and comparison with results of all isolated Staphylococci
verfasst von
D. C. Park
S. K. Lee
C. I. Cha
S.-O. Lee
M. S. Lee
S. G. Yeo
Publikationsdatum
01.07.2008
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 7/2008
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-008-0478-6

Weitere Artikel der Ausgabe 7/2008

European Journal of Clinical Microbiology & Infectious Diseases 7/2008 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.